PROMARK: Publications

Stacey, SN et al.
A germline variant in the TP53 polyadenylation signal confers cancer susceptibility.

Gudmundsson, J et al.
Genetic correction of PSA values using sequence variants associated with PSA levels.

Rafnar, T et al.
The genetics of prostate cancer

Cremers RG et al.
Androgenic alopecia is not useful as an indicator of men at high risk of prostate cancer.

Bosland, MC et al
Words of wisdom. Re: effect of dutasteride on the risk of prostate cancer.

Cremers RG et al.
Prostate cancer: Trends in incidence, survival and mortality in the Netherlands, 1989-2006.

Gudmundsson J et al.
Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.

Thorunn Rafnar, Julius Gudmundsson.
Promark: genetic prostate cancer variants as biomarkers. European Urology Today. October/November 2008.

Gudmundsson J et al.
A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer.

Cremers RG et al.
Urologists’ and GPs’ knowledge of hereditary prostate cancer is suboptimal for prostate cancer counseling: a nation-wide survey in The Netherlands